ACLA President Julie Khani to Lead Hologic Government Affairs; ACLA Board to Oversee Search Process for Association’s Next President
Washington, D.C. – ACLA Board Chair William G. Morice, MD, PhD, and President of Mayo Clinic Laboratories, released the following statement on the forthcoming departure of ACLA President Julie Khani:
“On behalf of ACLA’s Board and ACLA’s broader membership, we extend our sincere gratitude to Julie for her tremendous leadership and work over many years at ACLA. As a thoughtful and dedicated advocate for our industry and the patients we serve, Julie has helped to elevate the work and value of clinical laboratories within Washington and nationally, advancing major legislative, regulatory and legal priorities on behalf of ACLA and its members. She has been a transformational leader who has increased the size, reach and diversity of the association to make it stronger as we move forward.
We look forward to continuing our work together with her in the future and offer her our congratulations as she begins this next chapter with Hologic as the company’s Vice President of Government Affairs.
The ACLA Board of Directors will immediately launch a national search for her successor. At this critical time for our industry and patients, the ACLA team has the full confidence of the Board as they continue to advance meaningful solutions to support millions of Americans.”
The American Clinical Laboratory Association (ACLA) is the national trade association representing leading laboratories that deliver essential diagnostic health information to patients and providers. ACLA members are at the forefront of driving diagnostic innovation to meet the country’s evolving health care needs and provide vital clinical laboratory tests that identify and prevent infectious, acute and chronic disease. ACLA works to advance the next generation of health care delivery through policies that expand access to lifesaving testing services.